NHS Genomics Strategy

NHS Genomic strategy

Following the legacy of the 100K Genome Project (100KGP), NHS England in collaboration with Genomics England (GE) have formed seven Genomics Laboratory Hubs (GLH) to deliver the Genomic Medicine Service (GMS) in England. Steady work is ongoing to incorporate state-of-the-art technologies to facilitate the service. The hubs are required to implement ISO-15189:2012 accredited genomic testing according to the National Genomic Test Directory (NGTD).

The NHS Genomic Medicine Service Infrastructure.

The NHS Genomic Medicine Service Geographies: GMS, GLH, GMSA

Snippets from the Strategy that align with the vision of s-Test Genomics:

‘Priority 2.1 Systematically introducing new clinical indications for genomic testing and embedding comprehensive genomic testing within end-to-end clinical pathways.

‘Priority 2.2 Driving the use of precision treatments and optimising the use of medicines through genomics.

‘Priority 2.3 Enabling the rapid evaluation and adoption of affordable, efficient, and innovative genomic technologies.

‘Priority 3.1 Developing an interoperable informatics and data infrastructure that enables the NHS to use and share genomic data appropriately to improve patient care.

‘Priority 3.3 Enabling the NHS to use cutting-edge analytical tools and up-to-date variant databases to maximise diagnosis, access to precision medicine, and efficiency.

‘Priority 4.3 Ensuring ongoing alignment with clinical trials and national life sciences projects and supporting the growth of life sciences in the UK.